International Biotechnology (LON:IBT) Posts Earnings Results

International Biotechnology (LON:IBT) issued its earnings results on Tuesday. The company reported GBX (10.22) earnings per share for the quarter, Digital Look Earnings reports. International Biotechnology had a net margin of 82.27% and a return on equity of 27.35%. The business had revenue of GBX 46 million for the quarter.

International Biotechnology Stock Performance

LON:IBT opened at GBX 1,026.66 on Tuesday. International Biotechnology has a 12-month low of GBX 812 and a 12-month high of GBX 1,235. The company has a quick ratio of 0.32, a current ratio of 0.11 and a debt-to-equity ratio of 9.43. The firm has a market capitalization of £324.97 million, a PE ratio of 4.25 and a beta of 0.47. The firm has a 50-day moving average price of GBX 1,080.85 and a 200 day moving average price of GBX 1,009.76.

International Biotechnology Company Profile

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.